Home › Thyroid Cancer › California
Thyroid Cancer clinical trials in California
13 studies for Thyroid Cancer are looking for participants at sites in California.
Cities in California
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
- City of Hope Medical Center, Duarte
Recruiting
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT05229341Active Surveillance of Papillary Thyroid Microcarcinoma
- Cedars-Sinai Medical Center, Los Angeles
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT02609685cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Nov 4, 2026 · NCT05366881Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- University of California, San Francisco, San Francisco
RecruitingPhase 2
Ages 2 to 99 · All sexes · Updated Oct 21, 2026 · NCT05783323Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
- University of California, San Francisco (UCSF), San Francisco
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT05786924DESTINY-PANTUMOUR04
- Research Site, San Diego
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
- The Unviersity of California, San Francisco (UCSF), San Francisco
RecruitingPhase 2
Ages 2 to 25 · All sexes · Updated Jul 24, 2026 · NCT06458036Navigation Intervention for Adolescent and Young Adult Cancer Survivors
- KP Southern California - Department of Research & Evaluation, Pasadena
Recruiting
Ages 21 to 45 · All sexes · Updated Jul 6, 2026 · NCT07406087Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
- University of California, San Francisco, San Francisco
RecruitingPhase 2
Ages 13 and older · All sexes · Updated Jun 18, 2026 · NCT06961084A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- St Joseph Heritage Healthcare, Santa Rosa
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- City of Hope, Duarte
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
- Stanford Cancer Institute, Stanford
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Mar 17, 2026 · NCT04119024Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 10, 2026 · NCT04742608APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 27, 2025 · NCT03175224From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.